BlackRock Institutional Trust Company, N.A. - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 64 filers reported holding SECOND SIGHT MED PRODS INC in Q4 2016. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q4 2016$739,000
-40.4%
375,166
+6.6%
0.00%
Q3 2016$1,239,000
-1.7%
352,057
-0.0%
0.00%
Q2 2016$1,260,000
-13.6%
352,058
+16.6%
0.00%
Q1 2016$1,458,000
-18.3%
301,966
-0.4%
0.00%
Q4 2015$1,785,000
+0.2%
303,137
+0.9%
0.00%
Q3 2015$1,781,000
-26.6%
300,292
+68.5%
0.00%
Q2 2015$2,426,000
+38.0%
178,248
+30.0%
0.00%
Q1 2015$1,758,000
+467.1%
137,117
+353.9%
0.00%
Q4 2014$310,00030,2080.00%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q4 2016
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 431,582$4,428,0000.58%
AWM Investment Company, Inc. 234,965$2,411,0000.33%
DAFNA Capital Management LLC 39,800$408,0000.32%
AYM CAPITAL, LLC 15,193$156,0000.12%
CARL DOMINO INC 20,350$209,0000.11%
JW Asset Management, LLC 8,500$87,0000.06%
NumerixS Investment Technologies Inc 13,800$142,0000.05%
FIDUCIARY TRUST INTERNATIONAL LLC 14,100$145,0000.04%
Cubist Systematic Strategies, LLC 15,711$161,0000.01%
REGIONS FINANCIAL CORP 32,000$328,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders